Wolfgang Staehle

This inventor holds 33 USPTO granted patents and 5 published patent applications, plus 13 CIPO patents and 23 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 2006-2018.

USPTO Granted Patents = 33 (Patent Applications = 5)

% Patents Active = 9.1

CIPO Patents = 13

EPO Patents = 23 (Patent Applications = 23)

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 196(Granted Patents)

Location History:

Jugenheim, DE (2006)
Ingelheim, DE (2006 - 2018)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

Years Active: 2006-2018

Loading Chart...

Areas of Expertise:

Autotaxin Inhibitors

Kinase Inhibitors

Cyclopentane Derivatives

Piperazine Derivatives

Thiazole Derivatives

Fatty Acid Synthase Inhibitors

Pyrido-Pyrimidine Compounds

Phenylurea Derivatives

Tetrahydroquinoline Derivatives

Sulfonamides

Benzimidazoles

Urea Derivatives

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10118919 - 3-substituted cyclopentylamine derivatives (2018-11-06),

2. 9809552 - Piperazine derivatives as FASN inhibitors (2017-11-07),

3. 9790216 - 3-substituted cyclopentylamine derivatives (2017-10-17),

4. 9732032 - 3-aminocyclopentane carboxamide derivatives (2017-08-15),

5. 9718785 - 1,3-Disubstituted cyclopentane derivatives (2017-08-01),

6. 9670142 - 1,3-diaminocyclopentane carboxamide derivatives (2017-06-06),

7. 9527850 - Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist (2016-12-27),

8. 9452997 - Piperidine and piperazine derivatives as autotaxin inhibitors (2016-09-27),

9. 9416133 - Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors (2016-08-16),

10. 9283225 - Pyrido-pyrimidine derivatives (2016-03-15),

11. 9249114 - Thiazole derivatives (2016-02-02),

12. 9067938 - Pyrazolopyridinone derivatives as LPA receptor antagonists (2015-06-30),

13. 9029387 - Benzonaphthyridinamines as autotaxin inhibitors (2015-05-12),

14. 8912202 - N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists (2014-12-16),

15. 8859775 - Pyrazolopyridinone derivatives as LPA receptor antagonists (2014-10-14),

Title: The Innovative Journey of Wolfgang Staehle: Pioneering Patent Holder in Medicinal Chemistry

Introduction: Wolfgang Staehle, located in Ingelheim, Germany, is a distinguished inventor with 33 patents to his name. His work primarily focuses on innovative compounds aimed at addressing critical medical conditions, exemplifying the intersection of creativity and scientific rigor in the field of medicinal chemistry.

Latest Patents: Among his latest patents, Wolfgang Staehle has developed 3-substituted cyclopentylamine derivatives and piperazine derivatives that serve as inhibitors of fatty acid synthase. These innovative compounds are significant in the treatment of diseases such as cancer, cardiovascular ailments, central nervous system injuries, and various forms of inflammation. The specifics of these inventions, including their unique chemical formulations, underline Wolfgang's contribution to advancing therapeutic options in medicine.

Career Highlights: Wolfgang has had an impressive career with notable contributions in major pharmaceutical firms. He notably worked with Merck Patent GmbH and Merck Patent Gesellschaft mit beschränkter Haftung, where his research and inventions have played a crucial role in enhancing the medicinal chemistry landscape. His extensive patent portfolio reflects his commitment to innovation and the development of new therapeutic solutions.

Collaborations: Throughout his career, Wolfgang Staehle has collaborated with esteemed colleagues such as Kai Schiemann and Melanie Schultz. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise, which is crucial in driving innovation in complex scientific fields.

Conclusion: Wolfgang Staehle stands out as a prominent inventor in the realm of medicinal chemistry. His substantial patent holdings not only highlight his ingenuity but also showcase the potential for new treatments that can significantly impact health outcomes. As his work continues to evolve, Wolfgang's contributions will undoubtedly remain influential in the ongoing quest for medical advancements.